Executive Summary Dendritic Cell Therapy Vaccine Market : The global dendritic cell therapy vaccine market was valued at USD 9.73 billion in 2024 and is expected to reach USD 14.65 billion by 2032. During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 5.25%, primarily driven by increasing cancer prevalence and the growing demand for personalized immun... https://www.databridgemarketresearch.com/reports/global-dendritic-cell-therapy-vaccine-market